Business Description
Becton, Dickinson and Co
NAICS : 339112
SIC : 3841
ISIN : US0758871091
Share Class Description:
XSWX:BDX: Ordinary SharesCompare
Compare
Traded in other countries / regions
BDX.USA0R19.UKBOX.GermanyBDX.MexicoBDX.AustriaB1DX34.Brazil1BDX.ItalyBDX.SwitzerlandBDX-RM.Russia IPO Date
2014-10-27Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | 4.17 | |||||
| Interest Coverage | 5.41 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.15 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.9 | |||||
| 3-Year EBITDA Growth Rate | 3.3 | |||||
| 3-Year EPS without NRI Growth Rate | 28.5 | |||||
| 3-Year FCF Growth Rate | -3.7 | |||||
| 3-Year Book Growth Rate | 2.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.08 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 2.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.17 | |||||
| Quick Ratio | 0.74 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 111.64 | |||||
| Days Sales Outstanding | 46.99 | |||||
| Days Payable | 58.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.36 | |||||
| 3-Year Dividend Growth Rate | 4.6 | |||||
| Forward Dividend Yield % | 1.38 | |||||
| 5-Year Yield-on-Cost % | 1.69 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.07 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.22 | |||||
| Operating Margin % | 14.15 | |||||
| Net Margin % | 8.45 | |||||
| FCF Margin % | 15.22 | |||||
| ROE % | 6.63 | |||||
| ROA % | 3.13 | |||||
| ROIC % | 5.24 | |||||
| ROC (Joel Greenblatt) % | 30.76 | |||||
| ROCE % | 5.39 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.37 | |||||
| Forward PE Ratio | 29.79 | |||||
| PE Ratio without NRI | 19.07 | |||||
| Shiller PE Ratio | 43.51 | |||||
| Price-to-Owner-Earnings | 19.73 | |||||
| PEG Ratio | 4.06 | |||||
| PS Ratio | 3.2 | |||||
| PB Ratio | 2.48 | |||||
| Price-to-Free-Cash-Flow | 21.02 | |||||
| Price-to-Operating-Cash-Flow | 17.01 | |||||
| EV-to-EBIT | 32.41 | |||||
| EV-to-Forward-EBIT | 31.29 | |||||
| EV-to-EBITDA | 17.04 | |||||
| EV-to-Forward-EBITDA | 17.33 | |||||
| EV-to-Revenue | 4.07 | |||||
| EV-to-Forward-Revenue | 4.39 | |||||
| EV-to-FCF | 26.73 | |||||
| Price-to-Projected-FCF | 1.41 | |||||
| Price-to-DCF (FCF Based) | 2.23 | |||||
| Price-to-Median-PS-Value | 0.86 | |||||
| Earnings Yield (Greenblatt) % | 3.09 | |||||
| FCF Yield % | 4.79 | |||||
| Forward Rate of Return (Yacktman) % | 8.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Becton, Dickinson and Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 17,619.024 | ||
| EPS (TTM) (CHF) | 0 | ||
| Beta | 0 | ||
| Volatility % | 2.53 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (CHF) | 0 | ||
| 20-Day SMA (CHF) | 0 | ||
| 12-1 Month Momentum % | 2.59 | ||
| 52-Week Range (CHF) | 237.25744 - 243.41 | ||
| Shares Outstanding (Mil) | 283.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Becton, Dickinson and Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Becton, Dickinson and Co Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Becton, Dickinson and Co Frequently Asked Questions
What is Becton, Dickinson and Co(XSWX:BDX)'s stock price today?
The current price of XSWX:BDX is CHF243.41. The 52 week high of XSWX:BDX is CHF243.41 and 52 week low is CHF237.26.
When is next earnings date of Becton, Dickinson and Co(XSWX:BDX)?
The next earnings date of Becton, Dickinson and Co(XSWX:BDX) is 2025-02-06.
Does Becton, Dickinson and Co(XSWX:BDX) pay dividends? If so, how much?
The Dividend Yield %  of Becton, Dickinson and Co(XSWX:BDX) is 1.36% (As of Today), Highest Dividend Payout Ratio of Becton, Dickinson and Co(XSWX:BDX) was 1.71. The lowest was 0.29. And the median was 0.52. The  Forward Dividend Yield % of Becton, Dickinson and Co(XSWX:BDX) is 1.38%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers